The Mehmet Akif Ersoy Göğüs Kalp Damar Cerrahisi Eğitim Araştırma Hastanesi (IMAEH) hospital in Istanbul has joined the network of hospitals on Clinerion’s PRS platform.
The Istanbul Mehmet Akif Ersoy Hospital provides care for all medical indications, with specialization in cardiology and pulmonology. The hospital’s catchment area has a population of 4.5 M. It is the only training and research hospital for cardiovascular surgery on the European side of Turkey. It is also the only public hospital in Turkey with an international health accreditation awarded by the Joint Commission International.
IMAEH will have more than 600 beds in 2018, including an intensive care unit with 174 beds. With PRS IMAEH will be able to identify and recruit patients also in an emergency setting. IMAEH adds more than 2 million medical records and 260,000 patient lives to PRS.
Joining the PRS platform means that IMAEH will become more visible to international sponsors seeking sites for clinical trials. Patients at IMAEH will now have access to a wider range of treatment options and physicians at IMAEH will be able to offer a better standard of care.
PRS performs medical data analytics on EHR-based patient data from its network of partner hospitals for the purposes of patient search and identification for clinical trials, data generation for real-world evidence and market access activities. Clinerion guarantees patient privacy through the exclusive use of anonymized patient data, while still enabling the re-identification of candidates for clinical trials by authorized hospital staff via the use of its patent-protected “Anonymous Identification” (ANID) technology.
“We are very happy to join Clinerion and PRS,” says Dr. Mehmet Ertürk, Chief Physician of IMAEH. “Patients who are candidates for clinical trials can be analyzed accurately and effectively with PRS, whilst ensuring the very important protection of personal data, patient safety, reliability of operation and supervision. PRS allows a huge efficiency improvement in running clinical studies, by finding and identifying the target numbers of patients for enrolment in trials in a very short time and reliably. This will contribute to the increase in the number of clinical trials in our country.”
“IMAEH is a great addition to the PRS platform,” says Barış Erdoğan, Clinerion’s Head of EEMEA. “IMAEH is the only public hospital with a Phase-I Center in Turkey. Together, we will have the chance to facilitate phase II-IV trials by enhancing standard operating procedures and leveraging state-of-the-art technology to increase speed, efficiency and productivity.”
About Clinerion
Clinerion enables early patient access to innovative treatments through solutions for clinical trial patient recruitment, real-world evidence, and market access. Clinerion’s PRS accelerates clinical research by radically improving the efficiency and effectiveness of trial recruitment. Clinerion’s key patient data services include data-assisted protocol optimization, site feasibility evaluation and patient identification. Clinerion’s solutions allow member hospitals to participate in leading-edge, industry-sponsored trials and save time in patient recruitment. They enable pharmaceutical companies to gain time and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which remain under the full control of participating hospitals. Clinerion is a global data technology service company headquartered in Switzerland. Clinerion’s solutions comply with international patient privacy and data security regulations.
Clinerion website: www.clinerion.com
Clinerion’s PRS: www.clinerion.com/index/OverviewOurSolutions/PatientRecruitmentSystem
For more information, please contact:
Le Vin Chin
Head of Marketing and Communications
Clinerion Ltd
Margarethenstrasse 47, CH-4053 Basel, Switzerland
Tel.: +41 61 865 60 54
media@clinerion.com
